Positron emission tomography (PET) imaging targeting prostate specific membrane antigen (PSMA), as a novel imaging method, has demonstrated its potential as an adjoint or alternative imaging technique for PCa diagnosis. The gene discussed is FOLH1; the disease is posterior cortical atrophy.